Thursday, March 27, 2014
of university technology transfer offices to find the optimal path for
commercializing discoveries have been well documented,1-3 but the
offices are not set up to implement translational research directly. Indeed, a
growing number of universities are creating translational programs that operate
beyond the usual technology transfer track and aim to teach faculty how to
advance the discoveries themselves.
SPARK, Catalyst not only covers therapeutics and diagnostics but also has
projects for devices and digital health. Its teams work as discrete entities
that are guided by a project manager.
At least six universities in the U.S. and overseas have
started translational programs modeled partially on SPARK. Another 10 have
consulted with Mochly-Rosen and Grimes, and some are planning to launch
Disclaimer: C. Simone Fishburn is an adviser
to both the SPARK and Catalyst programs. She declares no conflict of interest.
C.S. SciBX 7(12);
Published online March 27, 2014
1. Edelson, S. SciBX 6(4); doi:10.1038/scibx.2013.78
2. Fishburn, C.S. SciBX 7(11); doi:10.1038/scibx.2014.303
3. Fishburn, C.S. SciBX 7(3); doi:10.1038/scibx.2014.77
AND INSTITUTIONS MENTIONED
(NASDAQ:AMGN), Thousand Oaks, Calif.
Carmenta Bioscience Inc., Palo Alto, Calif.
Icahn School of Medicine at Mount Sinai, New York, N.Y.
National Center for Advancing Translational Sciences, Bethesda, Md.
National Institutes of Health, Bethesda, Md.
Palo Alto, Calif.
Stanford University, Stanford, Calif.
Stanford University School of Medicine, Stanford, Calif.
(NASDAQ:TELK), Palo Alto, Calif.
University of California, San Francisco, Calif.
San Francisco, Calif.